State Ledger
Company profile

Equillium, Inc. CIK 1746466

Ticker
EQ (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
La Jolla, CA 92037
Fiscal year end
2025 (FY)
Market Data
Close
$1.42
Change
-$0.02
Change %
-1.39%
Volume
36,300

EQ · trading date Oct 9, 2026 · previous close $1.44 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$22.40M
Total assets
$31.89M
Total liabilities
$3.29M
Stockholders' equity
$28.60M
Cash & equivalents
$30.28M
Operating income
-$23.63M
Operating cash flow
-$22.75M
Capital expenditures
$48.0K

Fiscal year 2025, via 10-K filed 2026-03-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$22.79M
Free cash flow margin
—
Liabilities / assets
10.3%
Equity / assets
89.7%
CapEx / revenue
—
Operating cash flow / net income
1.02×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$22.40M $31.89M $3.29M $28.60M
2024 $41.10M -$8.07M $25.60M $6.54M $19.06M
2023 $36.08M -$13.34M $50.53M $27.96M $22.57M
2022 $15.76M -$62.43M $78.42M $46.48M $31.94M
2021 — -$39.05M $85.41M $18.90M $66.51M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-25

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
La Jolla, CA 92037
2223 AVENIDA DE LA PLAYA
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies